BioCentury
ARTICLE | Clinical News

Natesto regulatory update

February 9, 2015 8:00 AM UTC

Trimel submitted an NDS to Health Canada for Natesto testosterone nasal gel as replacement therapy in men for conditions associated with a deficiency or absence of endogenous testosterone. The bioadhe...